decompensated
美 
英
例句
Cirrhosis is usually described as compensated in its early stages and decompensated as liver failure develops.
肝硬化在早期阶段为代偿性，发展到肝衰竭阶段为失代偿。
All patients developed decompensated liver disease despite one patient having had a prior liver biopsy showing absence of cirrhosis.
所有的病人发展为失代偿性肝病，尽管其中一位经肝活检证实没有形成肝硬化。
Exogenous brain natriuretic peptide can significantly improve acute decompensated heart failure symptoms, related drugs already available.
外源性的脑钠肽可以显著改善急性失代偿性心力衰竭的症状，已有相关药物问世。
Hepatology Digest: What advances in pharmacological treatment can halt progression to decompensated cirrhosis or reverse cirrhosis?
《国际肝病》：目前对于阻止失代偿肝硬化进展或逆转肝硬化有哪些药物治疗进展？
The radical technique of treatment of the liver decompensated cirrhosis involves transplantation of liver.
肝硬化失代偿期肝病治疗技术涉及根治肝移植。
There was significant difference of TBA between the patients with compensated and those with decompensated cirrhosis (P0. 01).
肝硬化失代偿期患者的TBA水准显著高于代偿期患者（P0。01）。
Conclusions High HBV DNA level in patients with decompensated liver cirrhosis of hepatitis B may have effect on the decrease of PLT.
结论乙型肝炎肝硬化失代偿期患者高载量HBVDNA对血小板参数降低有一定的影响。
abstract: Objective: To explore clinical efficacy of Adefovir Dipivoxil in treatment of hepatitis B related decompensated cirrhosis.
目的：探讨阿德福韦酯治疗失代偿乙肝肝硬化的临床疗效。
contributed to the decreased incidence of decompensated liver disease.
促进了失代偿性疾病的发病率下降。
Acute decompensated heart failure is a growing public health care problem worldwide.
急性失代偿性心力衰竭日益公共保健问题全世界。
Recombined BNP is effective in cases of decompensated heart failure.
此外，重组脑钠肽对于失代偿性心力衰竭的疗效显著。
About 73% had no cirrhosis, 24% had compensated cirrhosis, and 2% had decompensated cirrhosis at baseline.
约73%的人没有肝硬化，24%有代偿性肝硬化，失代偿期在基线和2%肝硬化。
However, if you have advanced pre-decompensated cirrhosis, I don't think a biopsy is the best test.
但是，如果是晚期失代偿前肝硬化，那么我不认为活检是最好的检验手段。
Methods A retrospective analysis was made in 67 cases with decompensated cirrhosis suffered from the pulmonary infection.
方法对67例失代偿肝硬化并发肺部感染患者的临床资料进行了回顾性分析。
The 12-month all-cause mortality was 27. 4%, and was higher among those with decompensated congestive HF (33. 5%) than the denovo HF group.
12个月的全因死亡率为27.4%，并且失代偿性充血性心力衰竭组（33.5%）高于新发心衰组。
Clinical study of Lamivudine treatment in patients with decompensated cirrhosis
拉米夫定在失代偿期肝硬化的临床应用研究
Clinical characteristics of traditional Chinese medical type of syndrome of hepatocirrhosis decompensated period patients
肝炎肝硬化失代偿期患者中医证型临床特点分析
Multi-interventional therapy for hepatocellular carcinoma with decompensated hepatic cirrhosis
伴失代偿肝硬化的肝癌患者综合介入治疗
Clinical Study of Chinese Plus Western Medication in the Treatment of Decompensated Cirrhosis
中西药联用治疗失代偿肝硬变临床研究
Diagnosis of subclinical hepatic encephalopathy with evoked potentials in patients with decompensated hepatic cirrhosis
诱发电位检测在失代偿期肝硬化患者亚临床肝性脑病诊断中的价值
Correlation between B-natriuretic peptide and hemodynamics in patients with decompensated heart failure and clinical significance
心力衰竭患者脑利钠肽浓度与血流动力学的关系及临床意义
Effects of Lyophilized Recombinant Human Brain Natriuretic Peptide on Heart Rate Variability in Acute Decompensated Heart Failure
新活素对急性心衰患者心率变异性的影响
Clinical significance of peritoneal and retroperitoneal edema in patients with decompensated cirrhosis as demonstrated by CT scan
失代偿期肝硬化CT显示腹膜和腹膜后组织水肿的临床意义
Clinical Characteristics of Patients with Decompensated Cirrhosis and Concomitant Septic Shock
失代偿性肝硬化患者感染性休克的临床特征分析
Study on catheter lock solutions for maintenance of peripheral intravenous locks in patients with decompensated cirrhosis
肝硬化失代偿期病人静脉留置针封管液的探讨
Analysis of factors associated with prognosis in decompensated hepatic cirrhosis patients
失代偿期肝炎肝硬化患者的预后相关因素分析
Clinical effects of recombinant human growth hormone in patients with decompensated liver cirrhosis
重组人生长激素治疗失代偿性肝硬化临床研究
Establishment of Decompensated Cirrhotic Rat Model Complicated with Ascites
改良的肝硬化门脉高压伴腹水大鼠模型
Sodium metabolic disorder in decompensated cirrhosis patients and prognosis
失代偿期肝硬化患者钠代谢紊乱及其预后
A retrospective study of 42 death cases with decompensated hepatocirrhosis
42例肝硬化失代偿期死亡病例回顾性分析
Expression of ghrelin in gastric mucosa and serum ghrelin level in patients with decompensated cirrhosis
失代偿期肝硬化患者胃粘膜和血浆ghrelin改变及其临床意义
Analysis of prognosis of patients with decompensated liver cirrhosis using the criterion of the Model of End-Stage Liver Disease
失代偿期肝硬化患者的终末期肝病模型预后分析
Effect of Simvastatin on Myocardial Oxidative Stress during Decompensated Right Heart Failure in Rats
辛伐他汀对失代偿右心衰竭大鼠心肌氧化应激的影响
Managing Acute Decompensated Heart Failure: A Clinician's Guide to Diagnosis and Treatment
急性代偿失调性心衰：诊断与治疗临床医师指南
Clinical values of anti-virus treatment on decompensated cirrhosis patients
失代偿期肝硬化抗病毒治疗的临床价值
Effect of anti-endotoxin therapy on vaso-active substances in decompensated liver cirrhosis
抗内毒素治疗对肝硬化患者血管活性物质的影响
CT Findings of Edema of Colon and Peritoneum in Patients with Decompensated Cirrhosis
失代偿期肝硬化结肠和腹膜水肿的CT表现
Nesiritide: a safe and effective agent for acute decompensated heart failure
治疗急性失代偿性心力衰竭新药奈西立肽
Prognosis analysis of patients with decompensated liver cirrhosis using the model of end-stage liver disease
终末期肝病模型对失代偿期肝硬化患者预后的回顾性分析
progress in treatment of decompensated heart failure
失代偿性心衰治疗研究进行时
